These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 25361539)

  • 1. Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE.
    Devilliers H; Amoura Z; Besancenot JF; Bonnotte B; Pasquali JL; Wahl D; Maurier F; Kaminsky P; Pennaforte JL; Magy-Bertrand N; Arnaud L; Binquet C; Guillemin F; Bonithon-Kopp C
    Rheumatology (Oxford); 2015 May; 54(5):940-9. PubMed ID: 25361539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?
    Touma Z; Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2011 Sep; 38(9):1898-905. PubMed ID: 21724700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.
    Nantes SG; Strand V; Su J; Touma Z
    Arthritis Care Res (Hoboken); 2018 Jan; 70(1):125-133. PubMed ID: 28320078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus.
    Yilmaz-Oner S; Oner C; Dogukan FM; Moses TF; Demir K; Tekayev N; Atagunduz P; Tuglular S; Direskeneli H
    Clin Rheumatol; 2016 Mar; 35(3):617-22. PubMed ID: 25846834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients.
    Pamuk ON; Onat AM; Donmez S; Mengüs C; Kisacik B
    Lupus; 2015 Jul; 24(8):816-21. PubMed ID: 25542903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus.
    Harrison MJ; Ahmad Y; Haque S; Dale N; Teh LS; Snowden N; Ho P; Gorodkin R; Bruce IN
    J Rheumatol; 2012 Apr; 39(4):735-42. PubMed ID: 22298908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus.
    McElhone K; Abbott J; Sutton C; Mullen M; Lanyon P; Rahman A; Yee CS; Akil M; Bruce IN; Ahmad Y; Gordon C; Teh LS
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1505-13. PubMed ID: 26816223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C).
    García-Carrasco M; Mendoza-Pinto C; Cardiel MH; Méndez-Martínez S; García-Villaseñor A; Jiménez-Hernández C; Alonso-García NE; Briones-Rojas R; Ramos-Álvarez G; López-Colombo A
    Lupus; 2012 Oct; 21(11):1219-24. PubMed ID: 22875651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
    Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
    Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus.
    Devilliers H; Amoura Z; Besancenot JF; Bonnotte B; Pasquali JL; Wahl D; Maurier F; Kaminsky P; Pennaforte JL; Magy-Bertrand N; Arnaud L; Binquet C; Guillemin F
    Rheumatology (Oxford); 2012 Oct; 51(10):1906-15. PubMed ID: 22826305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus.
    McElhone K; Abbott J; Shelmerdine J; Bruce IN; Ahmad Y; Gordon C; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Teh LS
    Arthritis Rheum; 2007 Aug; 57(6):972-9. PubMed ID: 17665467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus.
    McElhone K; Castelino M; Abbott J; Bruce IN; Ahmad Y; Shelmerdine J; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Gordon C; Teh LS
    J Rheumatol; 2010 Nov; 37(11):2273-9. PubMed ID: 20810500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus-specific health outcome measure for US patients: the LupusQoL-US version.
    Jolly M; Pickard AS; Wilke C; Mikolaitis RA; Teh LS; McElhone K; Fogg L; Block J
    Ann Rheum Dis; 2010 Jan; 69(1):29-33. PubMed ID: 19126561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.
    Devilliers H; Bonithon-Kopp C; Jolly M
    Lupus; 2017 Apr; 26(4):396-402. PubMed ID: 27587460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus.
    Petri M; Kawata AK; Fernandes AW; Gajria K; Greth W; Hareendran A; Ethgen D
    J Rheumatol; 2013 Nov; 40(11):1865-74. PubMed ID: 24085548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
    J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus Derived from a Digital Therapeutic Plus Tele-Health Coaching Intervention: Randomized Controlled Pilot Trial.
    Khan F; Granville N; Malkani R; Chathampally Y
    J Med Internet Res; 2020 Oct; 22(10):e23868. PubMed ID: 33079070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.
    Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    J Rheumatol; 2018 Mar; 45(3):397-404. PubMed ID: 29419473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
    Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL).
    Ahmad Pouzi NA; Shaharir SS; Mohd Tamil A; Mustafar R; Ahmad Maulana S; Mageswaren E; Wan Ghazali WS
    PLoS One; 2023; 18(5):e0285461. PubMed ID: 37186611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.